Lv31
350 积分 2025-07-01 加入
Lung cancer
2小时前
待确认
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study
2小时前
已完结
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial
22天前
已完结
Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study
22天前
已完结
Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial
22天前
已完结
Increased D-dimer predicts the risk of cancer-associated recurrent venous thromboembolism and venous thromboembolism: A systematic review and meta-analysis
22天前
已完结
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
25天前
已完结
Common genetic driver mutation in NSCLC and their association with thromboembolic events: A retrospective study
29天前
已完结
Cancer-associated venous thromboembolism
29天前
已完结
Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline
29天前
已完结
皖公网安备34019202002308
